(Total Views: 521)
Posted On: 04/30/2021 12:49:48 AM
Post# of 149273
Re: nothingspecial #88589
Thank you for the reply. I will admit, I don't know "who" I would want as a replacement to NP. I am a finance person, not a biotech person.
But, I just see the results and am convinced we can do better. I guess we would need to leave it to the BOD to make that decision. (I'm no fan of the BOD either, so this is a challenge!)
But, if our drug works and we can't generate meaningful revenue during this current "opportunity" (cruel, I know), then our management has failed.
If our drug doesn't work, then so be it. We don't deserve revenue. (I think the drug works.)
IMO, those that say a new CEO will only look for a quick buck, a reverse split or a below market buy-out are off base. This just doesn't make sense. What I hear is that they don't want a CEO who is only hoping for the greatest home run in history. We already have one of those, and I don't see progress since early 2020. I want a CEO who can deliver revenue and a positive share price from HERE FORWARD.
I would love to make a few bucks now and continue my investment in a deep-pocketed partner with a lot of experience developing and marketing drugs. This would be better for me and also for the world that needs a Covid treatment for critical patients.
IMO, CYDY will have a higher stock price and save more lives under different management. Shareholder since January 2016. Currently hold 76,000 shares, which is about half my original position.
But, I just see the results and am convinced we can do better. I guess we would need to leave it to the BOD to make that decision. (I'm no fan of the BOD either, so this is a challenge!)
But, if our drug works and we can't generate meaningful revenue during this current "opportunity" (cruel, I know), then our management has failed.
If our drug doesn't work, then so be it. We don't deserve revenue. (I think the drug works.)
IMO, those that say a new CEO will only look for a quick buck, a reverse split or a below market buy-out are off base. This just doesn't make sense. What I hear is that they don't want a CEO who is only hoping for the greatest home run in history. We already have one of those, and I don't see progress since early 2020. I want a CEO who can deliver revenue and a positive share price from HERE FORWARD.
I would love to make a few bucks now and continue my investment in a deep-pocketed partner with a lot of experience developing and marketing drugs. This would be better for me and also for the world that needs a Covid treatment for critical patients.
IMO, CYDY will have a higher stock price and save more lives under different management. Shareholder since January 2016. Currently hold 76,000 shares, which is about half my original position.
(5)
(0)Scroll down for more posts ▼
